We present a case of bilateral retro-orbital haematomata following thrombolysis of pulmonary embolism in a severely haemodynamically compromised 29-year-old female. The haematomata developed two days post-thrombolysis with marked visual impairment. Visual acuity was restored following bilateral drainage of the superior aspects of the retro-orbital space.
It is widely accepted that massive pulmonary embolus with haemodynamic compromise and right heart failure is treated by thrombolysis [1] [2] [3] . However, thrombolysis is associated with a number of risks, notably major haemorrhage, which can be fatal 1 . Both right ventricular status and cardiac troponin I have been used as risk stratifying measures and predictors of mortality 4, 5 . We report a case of a massive pulmonary embolus with severe haemodynamic compromise and the unusual complication of bilateral retro-orbital haemorrhage after thrombolysis.
CASE HISTORY
A 29-year-old female had a past medical history that included mild asthma, polycystic ovarian syndrome for which she had taken cyproterone acetate/ethinyloestradiol for six months, and anaphylaxis to bee stings. Her family history included a sister who had a pulmonary embolism at the age of twenty-three years. Four weeks prior to her presentation our patient experienced left lower limb swelling, with a normal ultrasound scan. She complained of a three-day history of left calf pain. On the day prior to her admission she had had a five-hour car trip. On the day of admission she collapsed and was found to be in pulseless electrical activity on arrival in the emergency department. Cardiopulmonary resuscitation was commenced and was continued for two minutes, adrenaline was administered and she was intubated. Arterial blood gases taken on admission showed pH 6.69 (decreased 40 min later to pH 6.50) P a CO 2 63 mmHg, HCO 3 -7 mmol/l and base excess -25.3.
Cardiac troponin I was 0.8 µg/l (normal <0.5 µg/l). A transthoracic echocardiogram was performed showing a severely dilated right ventricle with markedly impaired function, abnormal septal wall motion, an estimated right ventricular systolic pressure of 46 mmHg, and an underfilled left ventricle. These features were consistent with an acute pulmonary embolism. Thrombolysis with recombinant tissue plasminogen activator was performed with an initial 10 mg bolus followed by a 90 mg infusion over two hours, and full anticoagulation with unfractionated heparin. A post-thrombolysis transthoracic echocardiogram showed markedly reduced right ventricular dilatation with mild systolic dysfunction and no elevated right ventricular pressures. She was extubated 34 hours after thrombolysis. Two days post-thrombolysis she developed bilateral marked proptosis with chemosis and reduced visual acuity (6/36 bilaterally), but no associated papilloedema. A CT scan of the orbits demonstrated large bilateral retro-orbital haematomata filling the superior halves of the post-septal orbits. These appeared to arise from the extra-conal spaces ( Figure  1 ). The haematomata were complicated by bilateral optic nerve traction, greater on the right. Anticoagulation was ceased. Exposure keratopathy subsequently developed. No lower limb or distal thrombosis was demonstrated on ultrasound examination. In view of the overall embolic risk, given that anti-coagulation had now been reversed with protamine and fresh frozen plasma administered, a temporary inferior vena cava filter was inserted. A review ultrasound on day 10 documented an inferior vena cava thrombosis below the filter. The filter was therefore subsequently left in situ.
Anti-coagulation was recommenced two days after IVC filter insertion as there had been no further deterioration in visual acuity. The retrobulbar subperiosteal haematomata were managed conservatively over the next 10 days with minor improvement in vision in the left eye. Vision in the right eye showed little improvement and a limited right subperiosteal aspiration of the superior orbital haematoma was performed with little effect radiologically or clinically. Subsequent bilateral formal surgical drainage of the superior aspects of the retro-orbital space was performed under general anaesthesia, resulting in a correction of her visual defects two days later. Anticoagulation was recommenced after drainage and no further complications were experienced. Three weeks after admission, visual acuity was normal and she was discharged home to remain on lifelong anticoagulation therapy. Thrombophilia screening demonstrated heterozygosity for the prothrombin gene mutation and this mutation has subsequently been found in her sister.
DISCUSSION
Life-threatening pulmonary embolism is appropriately treated with thrombolysis. Major haemorrhage is a recognised complication of this treatment. However, bilateral retro-orbital haemorrhage has not previously been reported in this setting. In this patient the bilateral retro-orbital haematomata developed two days after thrombolysis. Relief of symptoms and restoration of vision required surgical evacuation of the orbits 6 .
Insertion of IVC filters is a contentious issue in these settings, particularly in the absence of distal thrombosis 7 . The absolute indications for inferior vena cava filter insertion are very limited, but include patients with pulmonary thromboembolism who have an absolute contraindication to anticoagulation, and patients with recurrent pulmonary embolism despite anticoagulation 8 . Recurrent pulmonary thromboembolism in patients with filters is reported at rates varying from 0 to 4%. Rates vary also according to the type of filter used 8 . In 1998, Decousus and colleagues reported a randomized controlled trial comparing event rates in follow-up of patients with pulmonary thromboembolism, with and without filter insertion 9 . In this study, within the first 12 days pulmonary emboli occurred in 1.1% of patients with a filter and 4.8% of patients with no filter (P=0.03). During a twoyear follow-up period, symptomatic pulmonary emboli occurred in 3.4% of patients with a filter and 6.3% of patients with no filter (P=0.16). The recurrent deep vein thrombosis rate was 20.8% in the filtered patients and 11.6% in those without a filter (P=0.02). Complications of filter insertion include filter migration, filter penetration and filter thrombosis.
Although APACHE II scores do not relate to individual outcome, a score of 37 would correlate with an adjusted mortality of 85.3%. In patients with pulmonary embolism, high mortality is associated with right ventricular dysfunction, hypotension, acidosis and cardiac arrest 10, 11 .
Right ventricular strain and more recently, cardiac troponin I have been used as risk stratifying measures. Moreover it has been found that recovery of right ventricular function is associated with a reduction in morbidity and mortality 12, 13 . The recovery of right ventricular function post-thrombolysis is a marker of both efficacy of lysis as well as a predictor of in-hospital survival mortality 12, 13 . Prevention of right ventricular dysfunction in the long term improves survival and is an independent prognostic factor. Patients with acute pulmonary embolus with an elevation in serum cardiac troponin I have been shown to be at a higher risk of developing cardiogenic shock with an odds ratio of 8.85. In our case the patient had an elevated troponin I level (on admission was 0.8 µg/l which increased to 13.3 µg/l postthrombolysis). Elevated cardiac troponin I levels have been associated with elevated right ventricular systolic pressure and susceptibility to cardiogenic shock, but not mortality 5 .
A number of risk factors have been identified for venous thromboembolism 14 . In our patient these included use of an oestrogen-containing oral contraceptive pill, prolonged car travel, and heterozygosity for the prothrombin gene mutation. This report is, to our knowledge, the first case of thrombolysis-induced bilateral retro-orbital haematomata. In summary, the haematomata developed two days post-thrombolysis and was associated with marked visual impairment. Bilateral drainage of the superior aspects of the retro-orbital space resulted in restoration of normal visual acuity.
